Cnv Choroidal Neovascularization Market Synopsis

Cnv Choroidal Neovascularization Market Size Was Valued at USD  6.58 Billion in 2023, and is Projected to Reach USD 11.52 Billion by 2032, Growing at a CAGR of 6.42% From 2024-2032

• Choroidal neovascularization or membranes refer to new blood vessel formation on the layer of choroid tissue in eye linked to Retinal conditions including AMD, myopia and history of histoplasmosis. This condition may cause vision loss due to progression and contraction of the retinal membrane accompanied by scarring. CNV market comprises referencing all-orders medical therapeutic efforts aimed at the treatment or prevention of this condition; including the usage of anti-vascular endothelial growth factor (anti-VEGF) agents; laser and surgical treatment. With the new cases of the IICGCL and other retinal diseases more people are being diagnosed early thus the need for better treatment and this boost the following CNV market we also see this progressing in future helped by technological improvement in the medical field and the aging world population.
• CNV refers to the formation of new blood vessels in the choroid and is most closely associated with dry AMD, pathological myopia and some ocular inflammation. Market for CNV is developing gradually because of increasing prevalence of these diseases, which mainly affect elderly people. Nevertheless, CNV diagnosis has however been made easier by the recent technological advancements in diagnostic tools, for instance the OCT and fluorescein angiography. Global highly competitive CNV market offers a wide spectrum of options for the treatment utilizing anti-VEGF therapies, photodynamic therapy and laser photocoagulation, all of them preserving and regulating the neovascular growth and vision.
• Therefore, based on several factors, the growth of the market is market will be steadily furthered by the tendencies towards the development of new drugs and methods of their delivery including long-acting implants and gene therapies. Sanctions received for the initial therapeutic strategies, a brolucizumab and faricimab especially, have broadened alternatives regarding which patients could be treated. Also, increased literacy rate through diagnosing techniques aimed at amplifying treatment and patient self-diagnosis also contribute towards the market growth. However, things such as costly treatment, injections which have to be administrated more often, and differential sensitivity to therapies can slow down the growth of the market. In general and particularly considering the existing trends as the technological growth, the increasing availability of letter therapisches and shifting of attention to patient care, enormous growth of the CNV market is expected.

Cnv Choroidal Neovascularization Market Trend Analysis

Key Trends in the Choroidal Neovascularization Market

• One of thekey driving factors for the current market development of CNV is the growing number of the diseases related to the main cause of the CNV – AMD. Because the world’s population is aging, more persons are developing AMD, which in turn increases the need for better treatment methods. This demographic shift is most acute in the so-called developed countries experiencing cases associated with age-related eye diseases such as cataracts, glaucoma, macular degeneration, among others. Therefore, there is escalating emphasis on research for CNV in the pharmaceutical segment, to come up with unique treatments for this condition.
• Besides, the availability of treatment has been accompanied by the demand for proper diagnosis, where technologies like the optical coherence tomography (OCT) for proper detection and monitoring of CNV. Technologies mentioned make it possible to visualize retinal features and diagnose CNV at earlier stages therefore modifying the interventional approaches as required. Advanced imaging has shown to help patients because early diagnosis and treatment can be life changing and can save a patient’s sight. These factors involving aging population base and innovation in the technologies are creating high level of interest from both pharma major and researchers for the development of new therapeutic targets for CNV as well as healthy life for the patients.

Advancements in Personalized Medicine and Digital Health Technologies in the CNV Market

• Another vital trend of the market of choroidal neovascularization (CNV) is its personalization. New therapies, in particular, anti-VEGF agents are being individualized gear to the patient’s profile, which increases treat outcome and decreases the side effects in equal measure. It not only make patient happier but also make them more compliant to the treatment that has been recommended for them. Additionally, there is an increase in the number of cases where anti-VEGF are used in conjunction with corticosteroids, or photodynamic therapy. CNV currently has few treatments that can safely and effectively halt the progression of the disease; this strategy is therefore expected to give patients a better shot at saving their vision.
• Furthermore, one of the living features of the CNV market, is the application of digital health technologies, in transforming the patient management practice. Telemedicine, and other similar applied mobile health applications are making the follow-up process less cumbersome as well as improving the access of healthcare to the patients. They help to provide constant assistance to monitor patients’ disorders and get prompt interventions which result in the enhancement of the general quality of treatment. Altogether, these improvements suggest that the CNV market is not fixed and that better options are currently on the horizon for this disease, which will improve the sufferers’ quality of life.

Cnv Choroidal Neovascularization Market Segment Analysis:

Cnv Choroidal Neovascularization Market Segmented based on By Diagnosis , By Treatment and By End-Users.

By Diagnosis, Fluorescein Angiography segment is expected to dominate the market during the forecast period

• A fluorescein angiography is an important instrument in ophthalmology which allows the elimination of eyes’ blood vessels picture with great detail. The process involves administration of a fluorescent dye followed by infusion into the blood stream so as to outline the retinal vessels. As the dye flows through the vessels, high quality photos are taken using the special cameras, so that further examination of the structure and the function of the retina can be made. It is most helpful in the identification of many different types of retinal illnesses, such as diabetic retinopathy, AMD, and retinal vein occlusion. Due to a better definition of vascular changes and abnormalities, fluorescein angiography contributes to the diagnosis of these conditions at an early stage.
• It expected to increase due to the growing incidence of diabetes as well as the growing number of aged people, therefore, the application of fluorescein angiography in treatments. Since these eye diseases are on the rise the need for early diagnosis is increased as it can determine the result of the disease and eyesight. The detailed information actually acquired by using the technique of fluorescein angiography give additional details for correct diagnosis of the disease, evaluation of the subsequent course of the pathology as well as the adequacy of the applied treatment approaches. As people become more informed about the effectiveness of this diagnostic method, more individuals with vision issues will seek this diagnostic method in ophthalmic care to improve treatment and long-term results.

By  End-Users, Hospitals segment held the largest share in 2023

• The first end-users of ophthalmic diagnostic and treatment services are therefore hospitals, as they are the extensive, centralized focal points of the field of eye care. The use of classy technology with specialized ophthalmologists and health care personnel makes hospitals to offer services which range from simple check up to complicated surgeries. The need for these services is therefore increasing with the increasing eye diseases including cataracts, glaucoma and diabetic retinopathy and an increasing population of the elderly hence increased need for specialized eye care services. It shows that the hospitals should continue to play a key role in equipping the patients with the needed treatments on time.
• In addition, acting as key facilities for a majority of clinical research and trials in the specifics of ophthalmology, hospitals make their unique inputs to shape new practices and tools in the field. Hospitals should become involved in research projects because they offer an opportunity to test new treatments and develop existing processes to improve the efficiency of treatment benefiting patients. This fact of the dual role of ophthalmic establishments as providers of medical services and generators of medical knowledge strengthens the positions of hospitals in the ophthalmic market. However, hospitals will continue to be an important part of the healthcare industry’s delivery system of specialized eye care, while other players will contribute towards enhancing the functionalities that seek to enhance the quality of vision care among clients.

Cnv Choroidal Neovascularization Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North American CNV market also enjoys higher growth due to sound infrastructural development of the healthcare sector and high investment in the research and development in the region. This region has a good health care infrastructure that enables the delivery of sound medical solutions which the patients require to acquire the new solutions. The presence of most key players within the market also improves market dynamics, these are companies which are actively working on research of new treatments. The authorities of the USA provide the rapid permission to new therapeutics; moreover, the competition enhances the constant evolution of the treatment options for CNV.
• In the North American region, the United States occupies the largest market share for CNV because of the many CNV-related diseases like AMD. The prevalence of such disorders, complimented by increase in the aging population, creates a large need for treatment of disorders. Treatment options for CNV are significantly improved by innovative therapies, especially by anti-VEGF agents. This high demand coupled with the new clinical studies and advent of new therapeutic options make the USA one of the largest markets for CNV treatments and thus driving the growth of North American market.

Active Key Players in the Cnv Choroidal Neovascularization Market

• Pfizer Inc (U.S.)
• AstraZeneca (U.K.)
• Bristol-Myers Squibb Company (U.S.)
• Inc (Ireland)
• Reddy's Laboratories Ltd (India)
• Endo International plc (Ireland)
• Teva Pharmaceutical Industries Ltd (Israel)
• Sun Pharmaceutical Industries Ltd (India)
• Mylan N.V. (U.S.)
• Novartis AG (Switzerland)
• Regeneron Pharmaceuticals Inc (U.S.), Other Key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Cnv Choroidal Neovascularization Market by Diagnosis
 4.1 Cnv Choroidal Neovascularization Market Snapshot and Growth Engine
 4.2 Cnv Choroidal Neovascularization Market Overview
 4.3 Fluorescein Angiography
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Fluorescein Angiography: Geographic Segmentation Analysis
 4.4 Optical Coherence Tomography
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Optical Coherence Tomography: Geographic Segmentation Analysis
 4.5 Others
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Others: Geographic Segmentation Analysis

Chapter 5: Cnv Choroidal Neovascularization Market by Treatment
 5.1 Cnv Choroidal Neovascularization Market Snapshot and Growth Engine
 5.2 Cnv Choroidal Neovascularization Market Overview
 5.3 Anti-VEGF
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Anti-VEGF: Geographic Segmentation Analysis
 5.4 Photodynamic Therapy
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Photodynamic Therapy: Geographic Segmentation Analysis
 5.5 Thermal Laser
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Thermal Laser: Geographic Segmentation Analysis
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Geographic Segmentation Analysis

Chapter 6: Cnv Choroidal Neovascularization Market by End-Users
 6.1 Cnv Choroidal Neovascularization Market Snapshot and Growth Engine
 6.2 Cnv Choroidal Neovascularization Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Specialty Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Specialty Clinics: Geographic Segmentation Analysis
 6.5 Homecare
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Homecare: Geographic Segmentation Analysis
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Cnv Choroidal Neovascularization Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 PFIZER INC (U.S)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ASTRAZENECA (U.K)
 7.4 BRISTOL-MYERS SQUIBB COMPANY INC (IRELAND)
 7.5 REDDY'S LABORATORIES LTD (INDIA)
 7.6 ENDO INTERNATIONAL PLC (IRELAND)
 7.7 TEVA PHARMACEUTICAL INDUSTRIES LTD (ISRAEL)
 7.8 SUN PHARMACEUTICAL INDUSTRIES LTD (INDIA)
 7.9 MYLAN N.V. (U.S)
 7.10 NOVARTIS AG (SWITZERLAND)
 7.11 REGENERON PHARMACEUTICALS INC (U.S)
 7.12 OTHER KEY PLAYERS

Chapter 8: Global Cnv Choroidal Neovascularization Market By Region
 8.1 Overview
 8.2. North America Cnv Choroidal Neovascularization Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Diagnosis
  8.2.4.1 Fluorescein Angiography
  8.2.4.2 Optical Coherence Tomography
  8.2.4.3 Others
  8.2.5 Historic and Forecasted Market Size By Treatment
  8.2.5.1 Anti-VEGF
  8.2.5.2 Photodynamic Therapy
  8.2.5.3 Thermal Laser
  8.2.5.4 Others
  8.2.6 Historic and Forecasted Market Size By End-Users
  8.2.6.1 Hospitals
  8.2.6.2 Specialty Clinics
  8.2.6.3 Homecare
  8.2.6.4 Others
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Cnv Choroidal Neovascularization Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Diagnosis
  8.3.4.1 Fluorescein Angiography
  8.3.4.2 Optical Coherence Tomography
  8.3.4.3 Others
  8.3.5 Historic and Forecasted Market Size By Treatment
  8.3.5.1 Anti-VEGF
  8.3.5.2 Photodynamic Therapy
  8.3.5.3 Thermal Laser
  8.3.5.4 Others
  8.3.6 Historic and Forecasted Market Size By End-Users
  8.3.6.1 Hospitals
  8.3.6.2 Specialty Clinics
  8.3.6.3 Homecare
  8.3.6.4 Others
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Cnv Choroidal Neovascularization Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Diagnosis
  8.4.4.1 Fluorescein Angiography
  8.4.4.2 Optical Coherence Tomography
  8.4.4.3 Others
  8.4.5 Historic and Forecasted Market Size By Treatment
  8.4.5.1 Anti-VEGF
  8.4.5.2 Photodynamic Therapy
  8.4.5.3 Thermal Laser
  8.4.5.4 Others
  8.4.6 Historic and Forecasted Market Size By End-Users
  8.4.6.1 Hospitals
  8.4.6.2 Specialty Clinics
  8.4.6.3 Homecare
  8.4.6.4 Others
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Cnv Choroidal Neovascularization Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Diagnosis
  8.5.4.1 Fluorescein Angiography
  8.5.4.2 Optical Coherence Tomography
  8.5.4.3 Others
  8.5.5 Historic and Forecasted Market Size By Treatment
  8.5.5.1 Anti-VEGF
  8.5.5.2 Photodynamic Therapy
  8.5.5.3 Thermal Laser
  8.5.5.4 Others
  8.5.6 Historic and Forecasted Market Size By End-Users
  8.5.6.1 Hospitals
  8.5.6.2 Specialty Clinics
  8.5.6.3 Homecare
  8.5.6.4 Others
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Cnv Choroidal Neovascularization Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Diagnosis
  8.6.4.1 Fluorescein Angiography
  8.6.4.2 Optical Coherence Tomography
  8.6.4.3 Others
  8.6.5 Historic and Forecasted Market Size By Treatment
  8.6.5.1 Anti-VEGF
  8.6.5.2 Photodynamic Therapy
  8.6.5.3 Thermal Laser
  8.6.5.4 Others
  8.6.6 Historic and Forecasted Market Size By End-Users
  8.6.6.1 Hospitals
  8.6.6.2 Specialty Clinics
  8.6.6.3 Homecare
  8.6.6.4 Others
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Cnv Choroidal Neovascularization Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Diagnosis
  8.7.4.1 Fluorescein Angiography
  8.7.4.2 Optical Coherence Tomography
  8.7.4.3 Others
  8.7.5 Historic and Forecasted Market Size By Treatment
  8.7.5.1 Anti-VEGF
  8.7.5.2 Photodynamic Therapy
  8.7.5.3 Thermal Laser
  8.7.5.4 Others
  8.7.6 Historic and Forecasted Market Size By End-Users
  8.7.6.1 Hospitals
  8.7.6.2 Specialty Clinics
  8.7.6.3 Homecare
  8.7.6.4 Others
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research